ClinicalTrials.gov
ClinicalTrials.gov Menu

Ultrasound-guided Intervention and Hand Tenosynovitis in Patients With Diabetes Mellitus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03789526
Recruitment Status : Recruiting
First Posted : December 28, 2018
Last Update Posted : December 28, 2018
Sponsor:
Information provided by (Responsible Party):
Ahmed Abogamal, Al-Azhar University

Brief Summary:
Evaluates the efficacy of ultrasound guided versus clinically guided steroid injection in the management of tenosynovitis in DM patients.

Condition or disease Intervention/treatment Phase
Ultrasound Guided Injection Procedure: ultrasound guidance Not Applicable

Detailed Description:

The current study will based on follow up study, conducted among patients presenting at outpatient rheumatology clinics of Al-Azhar University Hospitals, Egypt. with Diabetes mellitus duration at least 3 years and tenosynovitis of hand tendons with Richie tenderness grade 3.

All patients will randomized in two groups: Group one: 26 patients DM patients with tenosynovitis were injected by triamcinolone under ultrasound guidance. Group two: 26 patients DM patients with tenosynovitis were injected by triamcinolone under clinical guidance.

The affected tendons will scanned and scored for inflammation using ultrasound in all patients before the triamcinolone injection and then to be reassessed one month after the injection to determine the change in the tendons in both groups.


Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 52 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:
  • Group one: 26 patients DM patients with tenosynovitis were injected by triamcinolone under ultrasound guidance.
  • Group two: 26 patients DM patients with tenosynovitis were injected by triamcinolone under clinical guidance.
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Ultrasound-guided Intervention and Hand Tenosynovitis in Patients With Diabetes Mellitus
Actual Study Start Date : December 11, 2018
Estimated Primary Completion Date : January 31, 2019
Estimated Study Completion Date : February 1, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Ultrasound

Arm Intervention/treatment
Experimental: Group 1
  • Group one: 26 patients DM patients with tenosynovitis were injected by triamcinolone under ultrasound guidance.
Procedure: ultrasound guidance
ultrasound guidance of tendon injection

No Intervention: Group 2
Group two: 26 patients DM patients with tenosynovitis were injected by triamcinolone under clinical guidance.



Primary Outcome Measures :
  1. change in Tenosynovitis pain [ Time Frame: one month ]
    changes in VAS scale for pain,

  2. change in Tenosynovitis tenderness [ Time Frame: one month ]
    changes in Richie index for tenderness.

  3. changes in ultrasound images of the Tenoasynovitis. [ Time Frame: one month ]
    changes in Gery scale images, and power Doppler images of the tendons



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • • Diabetes mellitus.

    • Disease duration 3 years or more.
    • Tenosynovitis of hand tendons with Richie tenderness grade 3.

Exclusion Criteria:

  • • Patients with recent hand trauma.

    • Patients with inflammatory hand arthritis.
    • Previous tendon surgery.
    • Previous tendon injection.
    • Patients with contraindication for injection as related infection, uncontrolled DM or bleeding tendency.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03789526


Contacts
Contact: Ahmed Abogamal, professor +201001972099 ahmedfathy15@yahoo.com

Locations
Egypt
Al-Azhar university hospitals Recruiting
Cairo, Egypt, 11311
Contact: Ahmed Abogamal    +201001972099    ahmedfathy15@yahoo.com   
Sponsors and Collaborators
Al-Azhar University

Responsible Party: Ahmed Abogamal, clinical professor of Rheumatology, Al-Azhar University
ClinicalTrials.gov Identifier: NCT03789526     History of Changes
Other Study ID Numbers: REC-AFMG 2018/6
First Posted: December 28, 2018    Key Record Dates
Last Update Posted: December 28, 2018
Last Verified: December 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Ahmed Abogamal, Al-Azhar University:
Tenosynovitis
ultrasound
diabetes mellitus

Additional relevant MeSH terms:
Diabetes Mellitus
Tenosynovitis
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Tendinopathy
Muscular Diseases
Musculoskeletal Diseases